10/02/2024 | Press release | Distributed by Public on 10/01/2024 18:00
The Company has established the Sustainability Vision for 2030, aiming to create economic and social value by solving global social issues related in the medical, mobility, and sustainable materials markets through integrating and orchestrating of diverse talents of our employees and technologies. Especially in the medical market, we are pursuing business opportunities across the entire company.
The Industrial Materials business operates globally, utilizing core technologies such as printing, molding, and metal processing to produce and sell decorative films, decorative molded products, and sustainable materials. In the U.S., we supply decorative films and molded products primarily to the mobility and the home appliance markets, while also providing injection-molded components for medical devices.
Founded in 1999, Cathtek is a U.S.-based company with a solid business foundation in injection molding and assembly technologies, and quality control systems for medical devices. The company supplies products for various diagnostic and testing devices, such as blood collection device, to medical device OEMs.
This equity acquisition marks the first step towards strengthening our Industrial Materials business in the medical market in line with the Sustainability Vision. Through this acquisition, we aim to acquire Cathtek's quality control systems, technologies, and customer base for medical devices, while creating synergies with our existing injection molding production capabilities and mold manufacturing technologies to expand our business.